4th Quarter - Report

ECOLAB INC. for ECOLAB INC

Firm
Client
Income
—
Expenses
$420,000
Expense method
A: Lobbying Disclosure Act definitions

What was lobbied

5 issue areas, each in the filer's own words, with who lobbied on it and where.

Environment/Superfund ENV

Discussions related to environmental policies and issues including water infrastructure, water reuse, water efficiency, water resource management, and sustainability. Discussions related to energy and water efficiency initiatives. Discussions related to the implementation of the Pesticide Registration Improvement Act, P.L.117-103. Discussions related to data center water efficiency and energy efficiency.

LobbyistCovered position, as disclosed
TIFFANY ATWELL —
JAMES R. BAILEY —
LEA MCCABE —

Contacted: SENATE; Energy, Dept of; Interior, Dept of (DOI); Environmental Protection Agency (EPA); HOUSE OF REPRESENTATIVES

Taxation/Internal Revenue Code TAX

Discussions regarding scope of Sec. 48D investment tax credit; Discussions related to corporate taxation; H.R.1, One Big Beautiful Bill Act (P.L.119-21) implementation.

LobbyistCovered position, as disclosed
TIFFANY ATWELL —
JAMES R. BAILEY —
LEA MCCABE —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Bills named: H.R. 1 (119th)

Trade (domestic/foreign) TRD

Discussions related to supply chain challenges. Discussions regarding trade policy and tariffs.

LobbyistCovered position, as disclosed
TIFFANY ATWELL —
JAMES R. BAILEY —
LEA MCCABE —

Contacted: State, Dept of (DOS); SENATE; Commerce, Dept of (DOC); Executive Office of the President (EOP); HOUSE OF REPRESENTATIVES

Energy/Nuclear ENG

Discussions regarding sustainable aviation fuel. Discussions regarding permitting reform. Discussions regarding Department of Energy programs for critical mineral production, including the use of resins as extraction technology. Discussions regarding optimization of power generation.

LobbyistCovered position, as disclosed
TIFFANY ATWELL —
JAMES R. BAILEY —
LEA MCCABE —

Contacted: SENATE; Executive Office of the President (EOP); Energy, Dept of; HOUSE OF REPRESENTATIVES

Pharmacy PHA

Discussions regarding biopharmaceutical manufacturing policy. Discussions regarding animal health.

LobbyistCovered position, as disclosed
TIFFANY ATWELL —
JAMES R. BAILEY —
LEA MCCABE —

Contacted: HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Food & Drug Administration (FDA); SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.